| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8309983 | Clinica Chimica Acta | 2016 | 23 Pages |
Abstract
Findings of the current study suggested that rivaroxaban mono-therapy result in shorter hospital stay compared to the standard-therapy. Implication of CYP2C9 and VKORC1 genotypes in determining dose of warfarin, however, remains to be further examined in larger cohort studies.
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Biochemistry
Authors
Linli Duan, Nuofu Zhang, Huang Yan, Yehui Guo, Cheng Hong, Xinyan Yang, Xiaofen Su, Rongchang Chen, Ying Zhou, Nanshan Zhong, Chunli Liu,